The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program

By sjmartinez • April 27, 2025

Hanauer SB, Torres EA, Aragon-Han P, Chapman JC, Swaminath AC, Arai R, Butnariu M, Lee TC, Rabizadeh S, Check M, Barrett TA, Hashash JG, Meister T, Yen EF, Kinnucan J, Stein DJ, Ziring D, Shaposhnikov R, Sinh P, Qazi TM, Yarur AJ, Monzur F, Dervieux T, Abraham BP. The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program. Pharmaceutics. 2025 Mar 27;17(4):428. doi: 10.3390/pharmaceutics17040428. PMID: 40284422; PMCID: PMC12030419.

Tags: adalimumab, Cedars Sinai DoM, clearance, Digestive Diseases, dose optimization, inflammatory bowel disease, pharmacokinetics; precision medicine, precision-guided dosing, Publications, real-world data, therapeutic drug monitoring

Stress Cardiac Magnetic Resonance Ischemia Burden and Cardiovascular Events: Post-Hoc Analysis From the ISCHEMIA Trial

Kwong RY, Heydari B, Abbasi S, Mongeon FP, Marcotte F, Friedrich M, Shaw LJ, Xu Y, Anthopolos R, Bekeredjian R, Monti L, Selvanayagam J, Lesiak[...]

Statin-Induced Decade-Long Stabilization of Noncalcified Coronary Plaque Despite a Zero Calcium Score

Karlsberg RP. Statin-Induced Decade-Long Stabilization of Noncalcified Coronary Plaque Despite a Zero Calcium Score. JACC Case Rep. 2025 Dec 5:106400. doi: 10.1016/j.jaccas.2025.106400. Epub ahead of[...]

The role of bioactive lipids and eicosanoid metabolites in acute exercise in adults: Insights into human cardiorespiratory fitness

Ambatipudi M, Roshandelpoor A, Guseh JS, Kosyakovsky LB, Alotaibi M, Cheng S, Jain M, Lewis GD, Ho JE. The role of bioactive lipids and eicosanoid[...]